PATENT CLAIM ANALYSIS

Application Number: 15743892
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "04400A"]

Abstract:
Provided are nanoparticle conjugates comprising a drug encapsulated in a gelatin nanoparticle the surface of which is functionalized with an antibody to which a siRNA is linked. Methods with the nanoconjugates for treating diseases are provided as well.

Claim (Index 5):
The conjugate of  claim 1 , wherein the siRNA is selected from the group consisting of a siRNA specific to mutant KRAS and siRNA specific to AXL.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 86.0
- Lexical Diversity: 1.29032
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13141122', '13930533', '16069854', '13693578', '15688484']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7609819003317055
- 35 USC 102 Novelty (BERT): 0.5051898218990909
- Combined Prediction Score: 0.7354026924884441
- Mean Citation Score: 238.141608
- Max Citation Score: 246.4478
- Similarity Product: 179.14879172326326

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test